Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Keritrina

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A generic cardio drug product. The drug Keritrina contains the active pharmaceutical ingredient nitroglycerin which is used for the treatment of heart disease.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Via Filanda, 5
  • Gessate
  • 20060 Milan
  • Italy

Keritrina Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Keritrina‘s full profile, request access.

Request full access to PitchBook

Keritrina Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Keritrina‘s full profile, request access.

Request full access to PitchBook